Health Care

Trials Show Inactivated Zika Virus Vaccine is Safe and Immunogenic

Trials Show Inactivated Zika Virus Vaccine is Safe and Immunogenic”

"In addition, NIAID is helping to develop an investigational mRNA Zika vaccine and a live-attenuated vaccine candidate created to protect against Zika and all 4 strains of dengue virus".

Three Phase 1 human clinical trials evaluating an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it was safe and well-tolerated in healthy adults and induced a robust immune response.

The second study tested two forms of a DNA-based vaccine created by NIAID scientists soon after reports surfaced linking Zika infection during pregnancy to birth defects. Of these 67 participants, a total of 55 received 2 intramuscular injections of the investigational vaccine at the same dosage each time, 4 weeks apart, while the remaining 12 participants received a placebo, at the same dosing parameters, according to a press release on the study. After the initial injection, the adults were given another dose four weeks and then eight weeks later.

"Zika remains a threat to USA military personnel and families of service members".

The ZPIV vaccine, made from inactivated Zika virus particles, was developed by US Army researchers, who in July previous year had agreed to give Sanofi an exclusive licence to complete testing and bring the product to market. They found this vaccine also produced an immune response, but it was not as strong. Each received either two or three 4-mg doses at various time intervals.

They found that 60 to 89 per cent of participants generated a neutralising antibody response to VRC5288, whereas 77 to 100 per cent of participants generated a neutralising antibody response to VRC5283.

To measure the effectiveness of the immune response, researchers extracted antibodies from the participants and injected them into mice.

Investigators announced that VRC5283 was advanced to a phase II trial in March 2017 that aims to enroll around 2,500 healthy participants ages 15 to 35 from the U.S., Puerto Rico, and Central and South America.

They wrote said the results from both trials are promising, but more research is needed to address key questions. The mice were purposefully infected with Zika virus.

Also, they raised concerns about the possibility of whether immunity to Zika from vaccination may alter the behavior of other flaviviruses, such as dengue viruses or dengue vaccination, which could have a clinical impact.

While Zika experts have not precisely determined the concentration of antibodies needed to protect against congenital infection, animal model studies are helping to provide useful insights. They noted that it took almost 30 years for a rubella vaccine to become available, and though Zika incidence has dropped in most countries, its spread has been wide and unpredictable.



Like this

Latest


06 Декабря 2017
Silicon Valley VC takes leaves amid harassment allegations
In May, Pishevar was arrested in a London hotel on suspicion of rape, Forbes reported . Definers Public Affairs has denied any involvement in work related to Pishevar.

06 Декабря 2017
What the new tax plan means for students
The Senate, which approved its tax reform package early Saturday morning, did not touch the graduate tuition exemption. Congress is beginning work on a compromise between the two separate tax plans passed by the House and Senate.

06 Декабря 2017
'Dozens injured' in German train collision
The incident took place near the Meerbusch-Osterath train station in North-Rhine Westphalia, the most populous state in Germany. German broadcaster ARD reported that about 50 people had been injured after the passenger train ploughed into a freight train.

06 Декабря 2017
Abbott Laboratories (ABT) Stake Decreased by Atlantic Trust Group LLC
Abbott Laboratories ( ABT ) shares are down -2.56% for the week and that has got investors and traders sitting up and taking note. Also Investorplace.com published the news titled: "Abbott Laboratories (ABT) a Buy on Strong Quant Score" on November 28, 2017.

06 Декабря 2017
Cardinals sign Mikolas to two-year deal
He signed with Yomiuri in 2015 and found immediate success, posting a 1.92 ERA in 21 starts during his first season in Japan. The Cardinals may have missed out on Shohei Ohtani, but they have landed another talented pitcher from Japan.

06 Декабря 2017
Guardiola Welcomes Fergie time After Another City Late Show
Manchester City will go into next week's hotly anticipated Derby against Manchester United eight points clear at the top of the Premier League .

06 Декабря 2017
Coroner called to scene of pipeline explosion
Police say neighbors aided the two victims and took them to a local hospital from where they then flown to Rockford. At this time investigators have not confirmed what led to the explosion near the area of Nachusa Road and Route 38.

06 Декабря 2017
Stars descend on Moscow for Federation Internationale de Football Association 2018 World Cup Final Draw
Spain will play Portugal; France will play Peru; Brazil will play Switzerland. But we will have an very interesting opening match with Saudi Arabia.

06 Декабря 2017
Helios and Matheson Analytics Inc. (HMNY): Examining the Technicals
The indicator is non-directional meaning that it gauges trend strength whether the stock price is trending higher or lower. Adept traders are generally able to focus on the bigger picture and not let one or two bad trades get them down.

06 Декабря 2017
Which Insider bought 80000 Shares Of PBF Energy Inc. (PBF)?
It turned negative, as 16 investors sold LADR shares while 21 reduced holdings. 47 funds opened positions while 158 raised stakes. The total amount of shares outstanding is 107.76 million, giving the company a market capitalization of about 3.51 billion.



Recommended